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1. Introduction 
Abdominal aortic aneurysm (AAA) rupture (RAAA) is defined as bleeding outside the 
adventitia of a dilated aortic wall. Ruptures are classified as free when they flow into the 
peritoneal cavity causing massive blood loss, usually associated with a high mortality rate, 
and as retroperitoneal which are characterized by minor blood loss since retroperitoneal 
tissues contain the hematoma. In a minority of cases AAAs rupture into the intestinal tract 
(frequently in the last portion of the duodenum) creating an aortic enteric fistula or into the 
cava vein. Differentiation between symptomatic and ruptured aneurysm is essential. Like 
patients with RAAA, individuals with symptomatic AAAs may present with a variable 
symptomatology ranging from mild tenderness to severe pain, but there is no blood outside 
the aortic wall at computed tomography angiography (CTA) or intraoperatively (Fig. 1).   
 
 
Fig. 1. Preoperative angio-CT showing a RAAA (panel A), and the intraoperative finding 
(panel B).  
Pain is related to the aneurysm itself as a consequence of an acute expansion of the wall, 
intraluminal hemorrhage or bleeding into the thrombus, or it can be caused by other factors: 
cholecystitis, diverticulitis, pancreatitis.  Patients who undergo elective AAA repair have the 
best prognosis, followed by patients with symptomatic aneurysms, who do not have 
hypotension, followed by patients with RAAA. The second of these must not be included in 
data concerning RAAA as they would artificially improve the outcome results. 
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The incidence of RAAA ranges between 5.6 and 17.5 per 100,000 person-years in the 
Western Hemisphere (Moll et al., 2006).  
2. Diagnosis, transfer and preoperative care 
The mortality rate associated with RAAA is especially high during transfer to the 
emergency room (ER) or other emergency settings and later in the operating theatre (OT). 
Most ruptures occur outside of the hospital and the time between onset of symptoms and 
arrival at the OT has been found to be critical in determining the final outcome. Funds have 
been provided by national and regional health organizations to plan specialized pre-hospital 
management and transportation, including the use of helicopters. 
RAAA should be suspected in all patients over 50 complaining of abdominal or back pain, 
hypotension, and presenting with a pulsatile mass (the classic triad presentation). The mass 
may be obscured in patients with a large abdominal circumference. An episode of syncope 
can be indicative of orthostatic hypotension. An emergency Doppler ultrasound (DUS) 
should be performed to confirm the diagnosis in those patients. The patient should be 
transferred to the nearest high-volume hospital where an expert vascular/endovascular 
surgical team is available. Patients needing elective and RAAA repair whose surgeons have 
high annual procedure volumes are more likely to survive after surgery. A volume-outcome 
relationship has already been demonstrated for elective AAA repair as well as for other 
operations (Cho et al., 2008; Heikkinen et al., 2002; Dueck et al., 2004). It is unclear if 
surgeons with high annual procedure volumes become more expert and therefore produce 
superior outcomes or if better surgeons producing superior outcomes garner more referrals 
and thus become high-volume surgeons. Vascular surgeons, in any case, have better 
outcomes than general surgeons. RAAA patients of high-volume surgeons trained in 
vascular surgery have an adjusted 30-day mortality rate of 40.5%, compared with 43.9% for 
all other surgeons, with an absolute risk difference of 3.4%. Although the absolute difference 
in adjusted 30-day survival between high-volume vascular surgeons (3.5%) and all other 
surgeons (5.0%) was smaller for elective repairs, the number of elective operations is higher 
with respect to the number of RAAA repairs (Cho et al., 2008; Harris et al., 1991). 
The statistics concerning surgeon volume and mortality suggest that it may be beneficial to 
regionalize RAAA repair to high-volume vascular surgeons. But the argument can also be 
made that regionalization can lengthen the time between the onset of symptoms and 
surgery while patients are being transferred from one hospital to another. Informed policy 
decisions concerning regionalization cannot be made until the time effect is compared with 
the benefit of being operated on by high-volume vascular surgeons. Patients may, however, 
prefer to undergo surgery closer to home, and this could nullify the small survival 
advantage for elective AAA repair.  
This controversy seems to have been partially resolved by Endovascular Ruptured 
Aneurysm Repair (EVRAR). In a recent study by McPhee et al. who analyzed data gathered 
in the USA between 2001-2006, EVRAR was found to be independently associated with a 
lower postoperative mortality risk than was open surgical repair  (odds risk 1.56), with the 
highest advantage found in high-volume centers for elective EVAR (McPhee et al., 2009). 
When a RAAA is suspected a blood sample should be taken for analysis and cross matched 
(a minimum 8 units of blood cells and 4 units of blood plasma should be prepared) and a 
large intravenous access and a Foley catheter should be placed simultaneously.  
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Optimal management guidelines for preoperative crystalloid infusion in patients with 
severe hypotension have not been established. Aggressive resuscitation during which 
large quantities of fluids are administered can elevate systolic blood pressure (SBP) 
causing rupture of the temporary aortic seal that forms leading to further blood loss and 
worsening of hypotension (Johansen et al., 1991). The optimal strategy, termed permissive 
hypotension, seems to be providing minimal fluid infusion and the pharmacological 
resuscitation necessary to maintain consciousness with a SBP of about 80 mm Hg (50-
90mm Hg) (Crawford 1991; Alric et al., 2003). When possible, red blood cells should 
always be used during resuscitation. There are no randomized trials comparing different 
types of resuscitation for RAAA. In a series of patients presenting with severe 
hypotension (SBP<90 mm Hg) survival was improved in those who received minimal 
fluid infusion and in whom permissive hypotension was maintained until they arrived in 
the OT (Bickell et al., 1994).  
An emergency ultrasound examination should be performed by an expert operator to 
confirm the diagnosis once the patient has arrived in the ER and, if the patient is 
hemodynamically stable (consciousness and SBP >90 mmHg), a CTA should subsequently 
be performed to examine the aneurysm anatomy, to identify the rupture site, to plan aortic 
cross-clamping (supra or infra-renal), and to analyze the feasibility of endovascular repair. 
The unstable patient (unconsciousness and SBP<90 mmHg) should be taken directly to the 
OT (Fig. 2). 
3. Open RAAA repair 
Once in the OT, the patient must be quickly prepared and draped so that the operation can 
begin after induction of anesthesia that can itself cause severe hypotension if curare is used. 
An intra-arterial line to monitor blood pressure, a central vein catheter, and a nasogastric 
tube should be placed. 
Conventional open surgical repair (OR), involving surgical exposure of the aorta and 
replacement of the aneurysm with a synthetic tube graft if possible, is the most common 
treatment for AAA. Its advantages include shorter operating times and limited overall 
systemic physiologic insult. A small (2-3 cm) iliac aneurysm or a moderate stenosis can be 
repaired at a later date. Systemic heparinization, which reduces bleeding complications, can 
be avoided although retrograde iliac flushing and injection of a heparinized flush solution 
into the iliac arteries is necessary to remove any soft clots and to reduce distal thrombosis. 
Once RAAA repair has been completed and before the aorta has been unclamped, which is 
always associated with significant hypotension, the anesthesiologist must verify that 
appropriate fluids are being administrated and that pressor agents and bicarbonate are 
prepared for use if required.  Once the repair has been performed in about 25-30% of cases 
the abdomen cannot be closed without significant tension from a swollen bowel or a 
massive retroperitoneal hematoma or both that could lead to postoperative abdominal 
compartment syndrome secondary to an increase in intra-abdominal pressure. To avoid that 
complication an early or delayed closure of the abdomen using a non-absorbable mesh 
covered with polyurethane is indicated rather than a decompressive laparotomy, as it seems 
to reduce graft infection and multiple organ failure development (Rasmussen et al., 2002). 
Open AAA repair is a complex, major operation with high morbidity and mortality due to 
the combined effects of surgical exposure, hemorrhage, and aortic clamping which may 
induce lower torso ischaemia-reperfusion injury.  
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Fig. 2. Flow-chart showing a simplified protocol for the management of RAAA. (OR: open 
repair, OT: operating theatre). 
4. Operative strategies for RAAA 
The main goal of surgery to repair RAAA is to obtain a safe, rapid, and effective proximal 
cross-clamping of the aorta to interrupt hemorrhage. Different intraoperative approaches 
and strategies with regard to surgical and anesthetic aspects can be used to obtain aortic 
control and to improve the postoperative outcome. 
4.1 The transperitoneal approach 
The most common open approach is the transperitoneal one through a midline abdominal 
incision. Most surgeons prefer this technique because they are more confident with it and 
because it provides wide exposure of the infrarenal as well of the suprarenal aorta. It is 
possible, in fact, to rapidly dissect the infradiaphragmatic aorta and to cross-clamp the aorta at 
this point. To gain aortic control the left lobe of the liver must then be retracted to the right and 
the gastrohepathic omentum is opened allowing entry into the lesser sac. A nasogastric tube is 
usually used to identify the esophagus, which is retracted to the left. It is then possible to 
expose the aorta between the diaphragmatic crura, which is dissected with an electrocautery to 
facilitate a rapid, safe clamp placement. Once aortic control is obtained the clamp on the 
subdiaphragmatic aorta should be placed on the infrarenal neck if possible. The supraceliac 
aortic cross-clamping must be as short as possible to reduce visceral and renal ischemia. Some 
surgeons prefer to perform supraceliac aortic cross-clamping routinely to control hemorrhage 
readily and to avoid damage to the left renal vein and/or the gonadic veins which may take 
place during an infrarenal neck dissection when there is a large hematoma in that area. Some 
concerns have been voiced with regard to this method because supraceliac cross-clamping can 
worsen the visceral and renal ischemia induced by hemorrhagic shock, which in turn could 
contribute to often fatal multisystem organ failure.32  
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4.1.1 The left retroperitoneal approach 
Some surgeons prefer the left retroperitoneal approach to the abdominal aorta because of 
the advantages that it offers with respect to the standard transabdominal access. It has, in 
fact, been associated with less severe intraoperative hypothermia, fluid loss, lower 
postoperative ventilatory deficit, and a shorter period of paralytic ileus (Chang et al. 1990). 
This exposure is, moreover, considered the approach of choice for patients with a so-called 
“hostile abdomen”, those who have undergone multiple intraabdominal procedures or 
pelvic irradiation. It can also be useful in obese patients and in cases of horseshoe kidney 
(Wahlgren et al., 2007).  
The approach provides wide access to the infradiaphragmatic aorta as a 10th intercostal 
incision is used allowing rapid control of the supraceliac aorta before the aneurysm is 
exposed through the hematoma. Some surgeons in fact, advocate its routine use for RAAA 
repair. A retrospective analysis (Chang et al., 1990) on RAAA treated via a retroperitoneal 
extended approach (10th intercostal incision, 25 pts) as opposed to a standard transperitoneal 
procedure (38 pts) revealed that there was a lower 30-day mortality (12% vs 34.%; p<0.05), 
less need for ventilatory support in the OT, and a shorter duration of paralytic ileus when 
the former was used. But a prospective randomized study (Cambria et al., 1990) analyzing 
the transperitoneal approach (59 pts) as compared to the retroperitoneal procedure (54 pts) 
reported finding no advantage to the former.  
Some concerns have been voiced with regard to this approach and especially concerning the 
difficulty in controlling the right renal artery, and, if the aneurysm is large, exposure of the 
right iliac artery could be technically demanding. It is important then that the surgeon be 
familiar with a procedure which, at best, is difficult. The retroperitoneal approach may, 
moreover, be contraindicated in patients undergoing active cardiac massage for 
resuscitation or with a questionable diagnosis. 
4.1.1.1 Balloon occlusion 
According to some surgeons safe aortic control can be attained using an aortic occlusion 
balloon (AOB) placed in the visceral aorta under fluoroscopic guidance enabling laparotomy 
while avoiding the risk of rupturing the aneurysm and causing  massive hemorrhage. 
Lieutenant Colonel Carl W. Huges first introduced the technique to repair traumatic rupture 
of the abdominal aorta in 1950 during the Korean war (Arthis et al., 2006). Many 
advancements have been made since then especially during the last decade. Newer 
techniques and materials are now used to obtain aortic control using a compliant AOB 
(Assar et al., 2009). The most common approach is to insert the AOB through a percutaneous 
transfemoral access using a 11 to 16 F sheath placed in the suprarenal or pararenal aorta 
over a stiff guidewire (Arthurs et al., 2006; Malina et al., 2005; Mayer et al., 2009). A 
compliant AOB is then passed through the sheath and inflated proximal to the RAAA. The 
sheath is advanced to support the inflated balloon from below to avoid distal dislocation. 
The sheath should be fixed firmly to prevent any displacement that can occur if blood 
pressure rises. The entire procedure should be performed under fluoroscopic guidance, but 
when this is unavailable confirmation of occlusion is generally associated to the loss of a 
palpable femoral pulse and an increase in blood pressure. 
A transbrachial approach has also been described for RAAA (Matsuda et al., 2003). In 1964 
Heimbecker first described remote transaxillary aortic control using AOB in RAAA 
(Heimbecker 1964). The advantages of transbrachial or axillary AOB placement is that the 
AOB inflated at the infrarenal aorta level does not interrupt the blood supply to the celiac, 
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supramesenteric, and renal arteries. Important concerns have, however, been advanced with 
regard to this approach, and, in fact, it does seem to present some disadvantages. This 
technique may, in fact, involve a cutdown procedure to access the brachial artery and at 
times this may require a second operating team and dissection of the median nerve, 
potentially increasing the time for AOB placement. Most AOBs are large, bare, stiff, and 
difficult to pass in a blind fashion across the arch of the aorta. Oblique imaging may be 
necessary to traverse the arch into the descending thoracic aorta, while placement of a large 
sheath in the brachial artery may cause additional ischemic complications in the upper 
extremity.  
Risks associated with AOB, the most catastrophic of which being that of provoking a free 
rupture in a contained RAAA, need be considered. A wire or catheter could feasibly exit 
through the site of the aortic rupture or the weakened aortic wall aggravating hemorrhage. 
Transfemoral AOB should then always be performed under fluoroscopic guidance to avoid 
this complication. Another potential obstacle could be percutaneously locating the common 
femoral artery in a hypotensive patient. Low et al (1986) reported a 58% success rate in the 
percutaneous cannulation of the common femoral artery to place an AOB in cases of 
traumatic exsanguinating hemorrhage. When the attempt fails, a femoral cutdown 
procedure is required and ultrasound-guided access techniques may be useful. The risk of 
visceral, spinal cord, and lower extremity ischemia in an already moribund patient is 
associated to any technique of proximal control depending on the extent of the preexisting 
shock and collateral flow. Aortic occlusion times vary and some surgeons limit balloon 
inflation time to 10 minutes with a variable period of deflation for reperfusion (Assar et al., 
2009) because intermittent aortic occlusion is better tolerated. This technique can also be 
applied to gain control of the iliac arteries once the aneurismal sac is opened to avoid iliac 
vein lesions if there is a large hematoma. 
4.1.1.2 Intraoperative Auto Transfusion (IAT) and red cell salvage 
IAT is a method of blood conservation that reduces the need for allogeneic blood 
transfusions during AAA surgery (Alric et al., 2003; Takagi H et al., 2007). In a systematic 
review including 2 small randomized controlled trials, Alvarez et al (2004) did not find 
evidence that IAT decreases exposure to allogeneic blood transfusions (ABT) during 
infrarenal AAA surgery. Since the time that review was written, the results of two large 
randomized controlled trials have been published. In a recent meta-analysis of randomized 
controlled trials published before 2007, Takagi et al reported that IAT reduces the risk of 
ABT in elective AAA surgery, and its use has been recommended even for RAA (Markovic 
et al., 2009). Once IAT becomes routine in all AAA surgeries and all operators have become 
familiar with it, its use may become commonplace during RAAA repair protocols.  
IAT has obvious advantages as blood volume and normothermia are maintained because of 
the rapidity with which blood is salvaged and returned to the patient. Two basic blood 
salvage and replacement methods are possible: washed and unwashed (whole blood) 
autotransfusion. Cell washing devices can theoretically remove potentially toxic byproducts 
of injured red blood cells, such as activated clotting proteins and activated complement, but 
they also eliminate beneficial blood components such as platelets and clotting proteins. 
Although heparin is added by the autotransfusion system, it is removed when the blood is 
washed by an autotransfusion device. Unwashed autotransfusions return not only platelets 
and proteins but also unwanted free hemoglobin and activated coagulation factors known 
to increase the frequency of transfusion-related coagulopathy or nephropathy and its use 
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has thus been entirely abandoned. Dilutional coagulopathy is considered the major adverse 
event related to the use of cell washing systems. Administration of fresh frozen plasma and 
platelets is recommended when more than 8 units of autologous blood have been returned 
(Marty-Ane et al., 1995). IAT is particularly useful in the treatment of massive hemorrhage 
during which rapid reinfusion of large volumes of blood can be lifesaving and it is most 
effective when the salvage and reinfusion of shed blood can be accomplished at flow rates 
compatible with the degree of hemorrhage. Postoperative coagulation disorders and 
hypothermia-induced coagulopathies are prevented to a large extent by autotransfusion 
which returns warmer blood products (Marty-Ane et al., 1995). 
4.1.1.2.1 Renal function 
The incidence (ranging between 26 and 42%) of renal failure after RAAA is remarkably high. 
Of patients with renal failure, 11-40% require postoperative dialysis with an associated 
mortality rate of 76-89% (Harris et al., 1991; Magee et al., 1992). Impairment in renal function 
has been associated with suprarenal cross-clamping, duration of cross clamping >30 
minutes, preexisting conditions of renal dysfunction (serum creatinine > 2 mg/dl), shock, 
and age over 80 (Bonventre 2007; Nicholson et al., 1996). The etiology of renal dysfunction is 
multifactorial and many who develop it have sustained major insult to other organs. 
Ischaemic renal injury affects the tubules at the level of the outer medullar, which primarily 
include the thick ascending loop of Henle and the S3 portion of the proximal convoluted 
tubule. Tubular cell death is now considered characterized by both necrosis and apoptosis. 
Necrosis results from profound cellular adenosine triphosphate (ATP) depletion and is 
characterized by a sequence of events that begins with loss of cell polarity and of the 
epithelial brush border, followed by the loss of the integrity of tight junctions and the 
appearance of integrins such as intercellular adhesion molecule 1 on the cell surface. These 
interact with leukocyte adhesion molecules to mediate an inflammatory response with the 
release of cytotoxic mediators. Cells then slough into the tubular lumen and further impair 
already compromised filtrate flow. Tubular cell apoptosis is also triggered by ischaemia 
through as yet uncharacterized mechanisms, also resulting in cell loss, but there is no 
inflammatory component, and the resultant apoptotic bodies are phagocytosed by 
macrophages or surviving epithelial cells. Apoptosis is also observed in the recovery phase 
during epithelial proliferation and probably has a role in restoring a normal tubular 
structure. Clinically, the initial observation is that of a loss of urinary concentrating ability as 
the medullary gradient dissipates, followed by a decline in urine output as tubules become 
obstructed and denuded (Bonventre 2007).  
Some intraoperative strategies concerning anesthetic and surgical aspects can be utilized to 
protect the renal parenchyma.  Use of mannitol, an osmotic diuretic and the earliest 
pharmacological agent utilized to protect renal function following vascular surgery, 
continues to be controversial. In a randomized controlled study, Nicholson et al reported 
that it  reduces renal injury following infrarenal AAA, but in a recent review Hersey et al. 
(2008) concluded that there is no evidence that mannitol preserves renal function during 
aortic surgery. Mannitol infusion, nevertheless, is the most commonly used method to 
protect renal parenchyma from ischemic damage and from ischemic-reperfusion injury. Its 
use has been shown to protect renal function during elective surgery when suprarenal aortic 
cross-clamping does not exceed 60 minutes (Deriu et al., 2001). The dose commonly used is a 
bolus of 25 mg IV administered before or immediately after aortic cross-clamping. Mannitol 
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seems to increase tubular fluid volume through its osmotic effect and by reducing tubular 
cell swelling and hence resistance to flow. Since it is a hydroxyl radical scavenger, it is 
effective in an ischaemia-reperfusion injury setting (Hersey & Poullis 2008). 
Another pharmacological therapy that can be begun before or during supraceliac aortic 
cross-clamping is fenoldopam mesylate, a dopamine-1 agonist receptor which improves 
plasmatic renal blood flow to the cortex and medullary regions.  The dose used to obtain 
renal effects is 0.05/0.003 µg per kilogram per minute, is well below that usually needed to 
lower systemic blood pressure (Halpenny et al., 2002; Gilbert et al., 2001).  There is no data 
on its usefulness during RAAA surgery, but those effects on renal function noted during 
aortic surgery probably could presumably apply to RAAA as well. 
Other drugs such as dopamine, dopexamine, calcium channel antagonists and natriuretic 
peptide have been proposed, but their use is still limited and further studies are needed. 
Several intra-operative surgical strategies are applicable to protect renal tissue from 
prolonged cross-clamping ischemia. Many surgeons utilise the local cooling of the kidneys 
to protect the tissue from protracted cross-clamping ischemia by cyclic or continuous 
perfusion of renal arteries with cold solutions (Ringer’s lactate or saline) (Allen et al., 1993; 
Kashyap et al., 1997). Ice slushes can be applied to the kidney surface to further ensure 
hypothermia, if exposure is retroperitoneal. But hypothermia of the renal parenchyma 
remains a problem when the kidney remains in situ, and the results found using this method 
are controversial with regard to the prevention of post-operative renal failure (Allen et al., 
1993). In the light of our research studies and preliminary clinical reports, we utilize short-
term kidney arterial blood reperfusion whenever clamping ischemia exceeds 30 min.  
Reperfusion is achieved by re-establishing pulsatile normothermic blood flow either through 
the repaired renal artery or, in the majority of operative procedures, through the Pruitt–
Inahara shunt (500-50-9F. Ideas for MedicineTM, Cryo-Life® Comp, St. Petersburg, FL, U.S.A.).  
 
 
Fig. 3. The temporary renal reperfusion is achieved by re-establishing pulsatile 
normothermic blood flow through a Pruitt–Inahara shunt (500-50-9F. Ideas for MedicineTM, 
Cryo-Life® Comp, St. Petersburg, FL, U.S.A.) when the procedure requires more than 30 min 
of renal artery cross clamping. The proximal end of the shunt is inserted into the tubegraft 
and its distal end into the renal artery. After 3 min of blood the aorta and the renal artery are 
clamped, the shunt is promptly removed and the renal artery reconstruction completed. The 
reperfusion is repeated every 30 min if necessary. 
This technique can protect renal parenchyma from prolonged clamping ischemia (up to 100 
min) (Deriu et al., 2001).  
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5. Postoperative complications 
The most frequent complications after surgery for RAAA are listed in Table 1.  
 
 Incidence Associated mortality 
Postoperative bleeding 12-14% - 
Colonic ischemia 3-13% 73-100% 
Respiratory failure 26-47% 34-68% 
Renal dysfunction 26-42% - 
Postoperative dialysis 3-18% 76-89% 
Myocardial infarction 14-24% 19-66% 
Major arrhythmia 19-23% 40-48% 
Congestive heart failure 18-21% 39-42% 
Multisystem organ failure 59-66% 65-71% 
Paraplegia and paraparesis 1.1-2.3% 45-53% 
Table 1. Major postoperative complications following open repair for RAAA. 
Uncontrollable haemorrhage during RAAA repair is a major cause of perioperative 
mortality (Davies et al., 1993; Milne et al., 1994 ). Patients with coagulopathic haemorrhage 
must undergo timely administration of fresh frozen plasma, platelets, cryoprecipitate and 
antifibrinolytic agents. But in patients arriving in the OT with signs of severe haemorrhagic 
shock, these measures may be insufficient to restore normal haemostatic function in the face 
of persistent hypoperfusion, acidosis and hypothermia by the end of the operation. In this 
clinical situation, intra-abdominal packing is recommended to control further bleeding, to 
optimize organ perfusion, and to correct metabolic disturbances in the intensive therapy 
unit (van Herwaarden et al., 2001). Concerns have been advanced with regard to this 
technique and the possibility of secondary intra-abdominal infective complications noted in 
13% in an early postoperative period and in 18% in a later phase and as a result the 
technique is not commonly used in open RAAA repair (Johnston 1994). 
Colon ischemia can develop as a single mucosal lesion or as necrosis involving the full-
thickness of the colon with or without perforation. Several factors are thought to be 
responsible for colonic ischemia:  severe hypotension, preoperative inferior mesenteric 
artery (IMA) patency, the presence of a collateral supply from the superior mesenteric, and 
the site of hematoma. The patency of at least one hypogastric artery is generally considered 
acceptable to ensure adequate intestinal perfusion. After RAAA repair the colon must be 
carefully inspected and in case of doubt the IMA should be reimplanted and/or the 
hypogastric arteries should be inspected by ultrasound examination to verify their patency. 
If colonic ischemia is suspected during the postoperative period, a colonscopy should be 
performed as it is considered diagnostic, and colon resection, associated with a high 
mortality rate (50%), may be necessary (Harris et al., 1991; Johnston 1994). 
Myocardial infarction, associated with an high mortality rate (20-65%), develops as a result 
of excessive cardiac workload due to blood loss, aggressive resuscitation efforts, clamping 
and declamping in patients often with pre-existing history of ischemic coronary artery 
disease %).61 Rapid diagnosis and treatment of this fatal complication is imperative. 
Multiple-organ failure (MOF) is the major cause of death in the intensive care unit after 
successful RAAA repair.62 Some factors such as suprarenal aortic cross-clamping and longer 
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operative duration of aortic clamping seem to be involved in its development (Bauer et al., 
1993). Infection and shock are the two most common clinical predisposing factors and 
processes such as severe tissue injury or pancreatitis that induce a major inflammatory 
response seem to be capable of initiating a cascade of events that culminates in MOF (Deitch 
1992; Haveman et al., 2008). Regardless of the cause, MOF generally follows a predictable 
course, beginning with the lungs and followed by hepatic, intestinal, and renal failure, in 
that order. Hematologic and myocardial failure are usually later manifestations of MOF, 
while the onset of alterations involving central nervous system alterations can occur either 
early or late. This classical sequential pattern of organ failure can be modified, however, by 
pre-existing disease or by a precipitating clinical event. Renal failure, for example, may 
precede hepatic or even pulmonary failure in subjects with intrinsic renal disease or in 
patients who have sustained prolonged periods of shock, while hepatic or myocardial 
failure may be an early or even the initial manifestation of this syndrome in a patient with 
cirrhosis or myocardial damage. These clinical exceptions illustrate the biologic principle 
that, although systemic responses are similar in patients developing MOF, the exact 
sequence of organ failure can be influenced by the individual's acute disease processes or 
physiologic reserve (Deitch 1992). 
One hypothesis concerning the development of MOF after RAAA surgery is based on the 
“two hit” theory: the rupture and repair of an AAA is a combination of two ischemic-
reperfusion injuries (Lindsay et al., 1999). The first ischemic event is hemorrhagic shock, 
which sets off an inflammatory response, followed by resuscitation causing the first 
reperfusion injury. The second ischemic event is aortic cross-clamping followed by the aortic 
declamping causing the second reperfusion injury. 
This theory supports the microcirculatory hypothesis of MOF according to which organ 
injury is related to ischemia or vascular endothelial injury. In the macrophage 
hypothesis, instead, prolonged activation of macrophages results in excessive 
production, surface expression, and liberation of cytokines and other products, which 
through a cascade effect involving humoral and cellular effector systems exert 
deleterious local and systemic effects. The former hypothesis includes several distinct 
but to some extent overlapping potential mechanisms of injury, including inadequate 
tissue and cellular oxygen delivery, the ischemia-reperfusion phenomenon, and tissue 
injury due to endothelial-leukocyte interactions (Reilly et al., 1991; Granger et al., 1988). 
There are, thus, many points in which the microcirculatory and macrophage hypotheses 
of organ failure overlap and interact (Deitch 1992; Pober & Cotran, 1990). Clinical and 
experimental observations have in fact clearly demonstrated that systemic inflammation 
adversely affects the microcirculation, while ischemia can exaggerate the host's 
inflammatory response to subsequent stimuli by activating neutrophils and priming 
macrophages (Deitch 1992). 
Prognosis appears to be directly related to both the number of organs that fail and the length 
of time the patient is in organ failure, but our ability to predict outcome in individual cases 
is not so precise as to supersede clinical judgment in determining when further treatment is 
futile.  
The first cause of death in the surgical intensive care unit is MOF, and the best treatment is 
prevention.  In spite of the development of new-generation antibiotics and ever more 
sophisticated techniques of organ support, our ability to save patients once MOF has set in 
has not appreciably improved over the last two decades (Deitch 1992). New therapeutic 
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strategies aiming to prevent and/or limit the development of the physiologic abnormalities 
inducing organ failure are needed to improve survival in these patients.  
6. Results after RAAA repair 
The mortality rate of RAAA remains exceedingly high; in fact with the exception of only a 
few series (Crawford 1991, Lawrie et al., 1980), it ranges between 30 and more than 70% in 
most reports (Mureebe et al., 2008; Bown et al., 2002; Johansen et al., 1991; Bauer et al., 1993). 
If these statistics include patients who died at home or during transportation to the hospital, 
the mortality rate approaches 90% (Dueck et al., 2004). Poor survival rates have been 
reported throughout the last few decades despite advancements in specialized pre-hospital 
management and transportation, rapid emergency diagnostic evaluation and aneurysm 
repair by high-volume vascular surgery teams, and sophisticated post-operative intensive 
care units (Darling et al., 1996; Bown et al., 2002; Alric et al., 2003; Bauer et al., 1993; Dueck et 
al., 2004; Antonello et al., 2009).  
In the light of high mortality rates and high hospital costs, some attempts have been made to 
identify pre-operative variables that might be used to select patients for surgery (Antonello 
et al., 2009; Boyle et al., 2003; Calderwood et al., 2004; Tambyraja et al., 2008a, 2008b). While 
this approach may be justified in our cost-effective age, its ethical and legal implications 
need to be pondered. The decision to deny operative treatment to a patient with a RAAA 
can be made only on an individual basis and can be justified only in those cases 
characterized by poor quality of life due to a precarious general clinical status or mental 
condition. Variables and scoring systems (Tab. 2), have recently been developed to identify 
patients with a prohibitive operative risk for RAAA repair.   
Among these, the Glasgow Aneurysm Score (GAS) seems to be the most simple and 
accurate in identifying those patients unfit for emergency repair surgery (Antonello et 
al., 2007; Korhonen et al., 2004). Sufficient data are still lacking in the literature with 
regard to these systems, GAS included, and large prospective studies are certainly 
warranted.  
The best approach to RAAA remains, in any case, prevention. DUS screening programs 
for AAA in men over 65 have recently been attempted to reduce mortality (Scott et al., 
1995, 2002; Lindholt et al.). The rationale behind these programs is that ultrasound is a 
valid, fast, safe method to detect AAAs, with an estimated sensitivity and specificity of 98 
and 99%, respectively, and that perioperative mortality for elective AAA is lower than 5% 
in most centers (Lindholt et al., 1999). The Multicenter Aneurysm Screening Study (MASS) 
results published in 2002 in the Lancet journal showed that ultrasound screening 
performed over a 29 month period in men between 65 and 74 reduced the AAA mortality 
risk by 42% (Ashton et al., 2002). Two other reviews on this topic were later published by 
Cochrane (Cosford et al., 2007) and Lindholt et al. who confirmed these findings and 
reported a significant mid-term reduction in AAA-related and overall mortality after 3-5 
yrs, data that has been verified by long-term analysis. There is, instead, insufficient 
evidence demonstrating usefulness in women. While ultrasound screening is relatively 
inexpensive, further analysis is needed, and all the latest findings concerning this subject 
must be examined carefully whenever health care administrators are considering 
population-based screening programs. 
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 Odds ratio (95%CI) 
Age >80 year 1.5-3 
Female sex 1.5-2 
Hypotension < 80mmhg 2.5-3.5 
Renal impairment  2-3.5 
Pulmonary disease 1.5-2.2 
Haemoglobin <8 g/l 1.8-2 
Hematocrit <30% 1.8-2.5 
Diabetes 1.3-1.8 
Coronary artery disease 1.7-2.2 
Suprarenal cross clamping 1.8-2.5 
 
 Area under the roc curve (95% CI) 




* Physiological and Operative Score for Enumeration of mortality and Morbidity 
° Glasgow Aneurysm Score 
§ Edinburgh ruptured aneurysm score 
Table 2. Principle risk factors and Scoring Systems developed to predict survival after open 
repair for RAAA. 
7. Quality of life after RAAA 
The long-term impact on quality of life after AAA repair is debatable. Health, of course, 
cannot be defined simply as the absence of disease and infirmity, but implies physical, 
mental, and social well-being. Traditional outcome measures with regard to vascular 
surgery, such as graft patency and complication rates, are certainly important. These 
measures tend, nevertheless, to reflect a technical point of view towards the procedure 
rather than concern for the impact that the event has had on the patient as a whole. 
Measuring quality of life (QL) before and after surgery is one way to evaluate the patient’s 
perception of health and well-being. In extreme situations, a technically successful operation 
might leave a patient significantly debilitated by morbidity associated with the surgery. This 
seems to be a very real possibility, in fact, for survivors of AAA repair, given the high 
operative morbidity and mortality rates. The most frequently used questionnaires are the 
Rosser index (Korhonen et al., 2003; Joseph et al., 2002) (a measure of physical disability and 
psychological distress) and the Medical Outcomes Study Short Form-36 Health Survey 
(McDaniel et al., 2000; Reemtsma & Morgan, 1997; Chetter et al., 1997) (Sf-36; a generic QL 
measurement tool) promoted by the American Society for Vascular Surgery and validated 
for use in patients with vascular disease.  
In studies utilizing the Rosser index, not widely validated for vascular patients, a significant 
reduction was found in the level of functional capacity in the RAAA group with respect to 
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patients who underwent elective repair (Magee et al., 1992; Hennessy et al., 1998). Biases 
emerged in these reports as the studies were small and the patients were not matched for 
comorbidities, so it is difficult to ascertain if the populations (elective vs emergency) were 
similar. 
Larger studies with matched populations (elective vs emergency) were performed using the 
SF-36 by Tambyraja et al. (2005) and Hill et al. (2007) who reported that there were no 
significant differences in QL in the two groups. These studies also suggested that long-term 
RAAA survivors had the same QL as those who underwent open elective repair surgery.  
8. Endovascular repair 
Endovascular aortic repair is a new catheter-based, imaging guided procedure that has the 
potential to redefine the traditional approach to the treatment of AAA. Since it was first 
described by Parodi in 1991 (Parodi et al., 1991), its role in RAAA repair continues to be 
debated. In fact, while most published data drawn from non-randomised studies (Mayer et 
al., 2009) suggest that EVRAR is feasible in selected patients and in institutions specialized 
in endovascular techniques, the only published randomized control study by Hinchliffe et 
al. (2002) showed no benefit in terms of mortality or complications. But since that trial   
included symptomatic but non-ruptured AAA patients it is difficult to interpret these 
results. Long-term findings are needed to assess if EVRAR effectively treats endoleaks, 
prevents late ruptures, and ensures stent-graft integrity. The potential advantages of 
EVRAR with respect to open repair, such as reduced blood loss, less need for transfusions, 
and shorter stays in the ICU seem to be due to a decreased physiological insult. As EVRAR 
obviates the need for laparotomy, direct surgical exposure, handling of abdominal contents, 
and aorto-iliac clamping, it is an attractive alternative and potentially helpful in reducing 
the mortality rate of RAAA (Ten Bosh et al., 2010; Harkin et al., 2007; Sadat et al., 2008; 
Dillon et al., 2007).  
Different strategies are employed to treat RAAA using endovascular therapy. 
Proximal aortic control during EVRAR is obtained using a balloon placed in the visceral 
aorta via the brachial or the femoral accesses. The use of a balloon occlusion device is 
however associated to the risk of renal and splanchnic ischemia and distal embolization 
does not prevent on-going blood loss from ilio-femoral arteries.   
The most common procedure is aorto-unifemoral graft. The advantage of this method is that 
the aneurysm is quickly excluded from the circulation since introduction and deployment is 
rapid, and the contralateral gate does not need to be engaged as opposed to the bifurcated 
endograft which can be time consuming in some situations. Stent grafts may offer wider 
applicability but can be used only when unilateral iliac anatomy is suitable, but a femoro-
femoral crossover is nevertheless required (Fig. 4). 
Thanks to the recent diffusion of the endovascular technique most RAAAs are treated using 
aorta-bi-iliac endografting, and no differences in outcomes have been found in the two types 
of endografts (Moll et al., 2011). 
Abdominal compartment syndrome is a major cause of death after EVRAR and increases 
short-term mortality up to 5 times compared to that in patients with normal intra-
abdominal pressure. All EVRAR patients should be monitored for this syndrome by 
frequent bladder pressure readings and open surgery must be considered when bladder 
pressure rises over 20 mm Hg (Djavani et al., 2011). The major concerns regarding 
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endovascular treatment in emergency situations are the patient’s hemodynamic condition 
and time delays during the preoperative work up. The Montefiore RAAA Management 
Protocol (Harkin et al., 2007) seems to provide solutions and foresees using the 
endovascular approach in all patients with presumed ruptured aortoiliac aneurysms. 
Recent studies on EVRAR outline the procedure’s many benefits observed in selected 
groups of patients with an anatomical suitability for EVAR, commonly reported at 60% 
(range 18-83%) (Ten Bosh et al., 2010, 2011). In those cases there was a reduction in the 
mortality rate, in the length of time spent in intensive care, and in the total time spent in 
the hospital traditionally associated with open repair. But due to heterogeneity and biases 
these results should be interpreted with caution (Sadat et al., 2008; Dillon et al., 2007). 
Large multicenter randomized controlled trials will establish the efficacy of EVRAR. 
 
 
Fig. 4. Post-operative angio-CT showing an aorto-unifemoral endograft with a femoro-
femoral cross-over performed for a RAAA 
A pilot study recently outlined the difficulty in carrying out that kind of study (Hinchliffe et 
al., 2006). Some of the problems included: obtaining informed consent from patients with 
hemodynamic instability, inclusion of patients unsuitable for EVAR as well as traditional 
repair, immediate availability of CTA instrumentation, expert endovascular teams, and 
endograft devices. 
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Despite an increase in the volume of patients undergoing elective AAA repair over recent 
decades, the number of patients with RAAA has not fallen significantly (Johansson et al., 
1994; Acosta et al., 2006; Wanhainen et al., 2008). Although the surgical mortality rate for 
elective AAA repair has steadily improved due to advancements in operative techniques 
and perioperative care and has fallen to less than 2% in specialized centres and 5% in less-
specialized hospitals, the mortality rate of RAAA has not significantly changed over the past 
three decades and still ranges between 30 and 70% according to recent reports (Heller et al., 
2000; Marty-Ane et al., 1995; Mureebe et al., 2008; Cho et al., 2008;  Darling et al., 1996). The 
high mortality seems to be related to a combination of hemorrhagic shock and lower torso 
ischaemia followed by reperfusion injury despite successful revascularization (Harris et al., 
1991; Bown et al., 2002) 
Given the poor outcomes after open RAAA repair and in the light of lower perioperative 
morbidity and mortality after EVAR, some centers have adopted EVAR protocols for RAAA 
repair. Excellent results have been reported by those centers where the mortality rate has fallen 
to as low as 30%(Ten Bosch et al., 2010; Visser et al., 2007). But despite these results this 
technique cannot be offered to all patients with RAAA due to anatomic considerations (short 
neck, poor iliac access) and it has been estimated that only about 60% are anatomically 
suitable. (Visser et al., 2007; Ten Bosch et al., 2010, 2011) Additional factors reducing the 
applicability of EVRAR are institutional limitations, such as the lack of trained endovascular 
surgeons and/or endovascular equipment. But beyond the inherent difficulties and limitations 
connected to its use, EVRAR seems to present very important benefits confirming its 
usefulness and value as a modern surgical option for RAAA repair (Veith et al., 2003). 
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